Abstract
Synopsis
Tendinopathy has become the accepted term to describe a spectrum of changes that occur in damaged and/or diseased tendons. Over the past 2 decades, there have been new insights into tendon pathophysiology of relevance to clinicians, including (1) better characterization of the overuse injury process and the resultant structural and functional disruption in chronically painful tendons, (2) improved understanding of the pathomechanics associated with chronic tendon injury, and (3) greater knowledge about the influence of lifestyle factors and drugs on tendon pathology. The implications of these new insights are discussed. J Orthop Sports Phys Ther 2015;45(11):833–841. Epub 21 Sep 2015. doi:10.2519/jospt.2015.5884
The current article is intended to update the reader on the science of tendinopathy pathophysiology. Over the past 2 decades, we have developed a greater understanding of the process of overuse injury in tendons. In particular, we highlight recent evidence supporting the concept of “looking beyond the tendon” to address extrinsic and intrinsic factors associated with tendinopathy, including an individualized biomechanical approach. The discussion also includes the terminology used to describe tendinopathy.
“Tendinitis,” “Tendinosis,” or “Tendinopathy”? The Challenges of Terminology
In the late 1990s, Maffulli et al65 advocated a shift in clinical terminology from tendinitis to tendinopathy. Both terms are typically used as generic descriptors for pain/swelling of injured tendon, without distinguishing involvement of tendon versus paratendon or presence/absence of inflammation.65Tendinopathy is an umbrella term that indicates a nonrupture injury in the tendon or paratendon that is exacerbated by mechanical loading. The term is typically used to describe the same conditions previously identified with the term tendinitis. Newer evidence4,10,11,15,35,40,54,56,72,101,102 does indicate that inflammation accompanies, and can cause, the development of tendon overuse injury.
The terminology in relation to the description of tendinopathies has further broadened since the early 1990s, though inconsistencies in the use of nomenclature remain. Tendinosis is a term that has been used to describe chronic mid-portion tendon pathology as described above; however, specific definitions vary (compare the Oxford Medical Dictionary, 8th edition to The Oxford Dictionary of Sports Science and Medicine, 3rd edition). The term tendinosis is used by some in preference to tendinitis to shift the focus away from inflammation. The term tenosynovitis refers specifically to pathology of a fully developed synovial sheath (eg, finger flexors/extensors), which typically presents with acute swelling with or without crepitus and triggering. Paratendonitis or peritendinitis describes involvement of the paratendon, alone or in combination with tendinosis. The clinical presentation of paratendonitis can be very similar to that of tendinosis (insidious onset of load-related tendon pain and thickening, with or without morning stiffness), and the two often occur together.
Tendon Pathomechanics
In 1992, Gross42 extensively summarized the current state of knowledge about tendon pathomechanics and healing. The model presented by Gross42 held that when tendons are chronically exposed to volumes or magnitudes of loading (tension, compression, friction) that are beyond their physiological capacity, they experience cumulative cycles of injury, inflammation, and repair, leading to pain and swelling (tendinopathy). The resulting accumulation of poor-quality repair tissue in tendons is analogous to the healing after acute injury (eg, laceration or rupture), except that with overuse tendinopathy, the injury-repair response evolves gradually over time. The onset is typically insidious, and the prognosis for a patient presenting with chronic symptoms is either a frustratingly slow resolution or failure to resolve and inability to return to full activity. Without proper rehabilitation guidance to address potentially related pathomechanics, many individuals with tendinopathy are caught in a cycle of chronic and acute-on-chronic pain as they attempt to return to activity with a poorly healed and deconditioned tendon, leaving risk factors and root causes, including factors related to the kinetic chain, unaddressed.58
Characteristic Structural Changes in Tendinopathic Tendon
The general composition and organization of normal, healthy tendons have been well described previously and are only briefly summarized here (FIGURE 1).42 The classic description of the tensile load-bearing region of tendon includes 3 main components: (1) type I collagen fibers, which are predominantly longitudinally oriented; (2) a well-hydrated, noncollagenous extracellular matrix (rich in glycosaminoglycans); and (3) cells. The predominant cell population in healthy tendon is traditionally categorized as collagen-producing fibroblasts, responsible for the synthesis of the collagen fibers and extracellular matrix.42 In addition to the primary load-bearing part of the tendon, there is an extensive network of septae (endotendon), where the nerves and vessels are mainly located. Throughout the body, there are also structures closely associated with tendons (bursae, sheaths, reflection pulleys, underlying joint capsules, etc). These other structures should be assessed if possible, as they may contribute to symptoms—particularly when they impinge on the tendon or inhibit its gliding action through the development of adhesions.

Patients with tendinopathy display tendons that are thicker, but with reduced energy-storing capacity, meaning that for the same load, their tendons exhibit higher strains than those of healthy individuals (FIGURE 2).8,45 This represents a decline in both the structural and material properties of the tendon tissue. Indeed, abnormal tendon histology is correlated with reduced load-bearing capacity.88

It may be worth noting that although the stiffness (deformation in response to tensile load) of the tissue is, on average, lower in tendinopathic tendon, this phenomenon is unrelated to the sensation of increased “stiffness” often mentioned by individuals with tendinopathy, which is likely related to sensory and motor changes. These are separate phenomena with different definitions, but they happen to have the same term in the English language.
Prominent features of chronic tendinopathy histopathology (FIGURE 1) include the following: a disorganization of collagen fibers, an increase in the number of vessels and sensory nerves,5,26,27,90 an increase in the hydrated components of the extracellular matrix,91 a breakdown of tissue (tendon/endotendon/paratendon) organization,48 and haphazardly arranged proliferation of smaller, type III collagen fibers.81,84 There are frequently areas of cell death (eg, hypocellularity)69 or, alternatively, of fibroblast reaction (eg, hypercellularity and adhesions).57 Indeed, it is typical to find both degenerative and reactive changes within the same biopsy, even in very severe, long-standing cases. It is also postulated that there is a resident population of fibroblast-like cells within tendons that, after injury, can differentiate into several lineages (osteoblast, chondrocyte, adipocyte, tenocyte), leading to metaplasia (eg, bony, cartilaginous, or adipocyte transformation).86 Metaplasia is not usually discernible on imaging, unless the ossification is advanced, but is frequently encountered in biopsy specimens (reviewed in Lui62). The implication is that patients with chronic symptoms and evidence of structural change on imaging typically have profound underlying abnormalities that will not be quickly resolved, and that are associated with the loss of tendon function.
At the cellular level, several authors have reported increased numbers of leukocytes (especially macrophages and mast cells) in chronically painful tendons (rotator cuff, patellar and Achilles tendons),26,56,72,90 as well as increased numbers of vascular cells (endothelial and smooth muscle).93 However, compared to the more immune-driven pathologies, such as rheumatoid arthritis, with measurable systemic inflammation, the number of leukocytes is small. In other words, there is indeed an inflammatory reaction within chronically painful tendinopathy, but to a lesser extent than that of immune-driven rheumatological disorders. Macrophages with accumulations of hemosiderin in their cytoplasm are more prevalent in tendinopathic than in normal tendon74; hemosiderin is an indicator of prior injury that resulted in an activation of the innate immune response. At a biochemical level, the cells in painful tendons produce increased levels of glycosaminoglycan and inflammatory mediators such as substance P and prostaglandin E2 (PGE2).34,37,41 Substance P is released by peripheral sensory nerves87 and repetitively stretched tendon fibroblasts,11,13 and activates local mast cells that may contribute to pain and fibrosis.59 Tendon cells derived from tendinopathic tendon produce more PGE2 than cells from healthy individuals, indicating a chronic upregulation.37 Taken together, the evidence suggests that during the rehabilitation process, any worsening of edema, morning stiffness, or delayed-onset pain should be closely monitored and controlled, as inflammation could drive the tendon further down the pathological path. An early return to sport before adequate tendon load-bearing capacity is a significant risk factor for recurrence of Achilles tendinopathy.39
As a general rule, therapy should promote repair/remodelng rather than further injury/inflammation.33 However, it should be pointed out that there is often a discrepancy between clinical improvement and structural improvement as measured with clinical imaging; that is, we do not yet have a good clinical outcome measure for tendon remodeling. At the microscopic level, as a tendon heals, vessels and nerves regress1; collagen fibers become stronger; and the tendon becomes less thickened, more resistant to load, and less prone to reinjury (ie, recovering a more normal stress-strain curve).89 Longer-term ultrasound follow-up of resolved tendinopathies does indicate a reduction in tendon thickening and improved collagen alignment.76 This is an important point, as some authors have advocated reinjuring the tendon through treatments such as intratendinous needling and injections, aggressive soft tissue therapy, etc. These approaches may improve the patient's symptoms in the short term, but could result in long-term damage to the tendon. In addition to clinical trials that show a lack of effect of this type of approach (eg, de Vos et al29), the rationale is not well supported by current knowledge of pathology as outlined above.
Development of Tendon Pathologies Due to Overuse: Insights From Animal Models
Animal studies over the past 2 decades have demonstrated that tendons respond to overuse with a limited cellular and biochemical inflammatory response involving macrophages, mast cells, and resident fibroblasts. After 6 weeks of intensive concentric/eccentric kicking exercise, a paratendonitis with accompanying structural changes in the rabbit Achilles tendon is observed10; the recruitment of inflammatory cells to the paratendon appears gradually over the course of 6 weeks, and macrophages (rather than neutrophils or lymphocytes) predominate in the infiltrate.4 After 3 or 4 weeks of repetitive reaching and grasping, a widespread inflammatory cell infiltrate is observed throughout overused rat forelimb and tendons, as well as a low-grade upregulation of inflammatory cytokines in the flexor tendons.15,40 This inflammatory activity increases with more prolonged exposure to overuse.32 Within the endotendon, an intrinsic inflammatory response develops in response to repetitive tensile loading91—intrinsic because inflammatory cytokines, which are known to trigger collagen degradative activity, are produced by a subpopulation of tendon cells that reside in the endotendon. At the rabbit elbow, repetitive muscle stimulation upregulates intrinsic inflammatory and angiogenic pathways within local tendon cells.75 The origin of increased vascularity in tendinopathy may result from local vascular hyperplasia as a result of angiogenic factors like vascular endothelial growth factor, expressed by repetitively stressed tendon fibroblasts.6
One of the main proinflammatory substances involved in tendon injuries, prostaglandin E2 (PGE2), is produced both intrinsically (by repetitively strained tendon fibroblasts)3 and by leukocytes.92 PGE2 depresses collagen synthesis in tendon cells and upregulates their degradative enzyme activity.16 Chronic inflammation in the paratendon that is experimentally induced (eg, by injections of substance P or prostaglandins) causes or exacerbates tendinopathy.102 Taken together, the animal studies have taught us that the end result of overuse—tendinopathy—can develop as a result of repeated release of inflammatory and reparative mediators.
Low-grade inflammation may come and go in short bursts following a period of intensive mechanical loading, making it difficult to detect clinically. For example, in response to repetitive loading of tenocytes, many inflammatory genes are upregulated after 4 hours, but return to baseline levels within 24 hours.73 However, the extent of inflammatory and fibrotic activity can also gradually increase over a period of several weeks with prolonged exposure to repetitive loading35; the tendency of inflammatory activity to increase over time is more marked in older, compared to younger, tendons.54 Nevertheless, transient bursts of inflammatory activity in a tendon, if repeated and prolonged, can lead to the progressive accumulation of damage, even if these episodes are not registered as symptomatic by the patient.
The mechanism of tendinopathy pain relief in response to nonsteroidal anti-inflammatory drugs (NSAIDs)19,80 is not known, but NSAIDs are known to influence sensory nerves,32 tenocytes,85 and mast cells,111 in addition to their well-known effect on macrophages and neutrophils. The majority of animal studies that have examined the impact of NSAIDs on tendon healing (Achilles, plantaris, or flexor digitorum) after acute injury have found improved tendon healing (fewer adhesions, improved recovery of biomechanical properties),22,31,36,104,105 which supports the concept that ongoing tendon inflammation may be considered pathological. In contrast to the above studies of tendon injury, NSAIDs appear to be detrimental to bone-to-tendon (enthesis) healing after acute injury in rats21,23,25 (similar to their inhibitory effect on fracture healing) and may also be detrimental to muscle repair when used long term.64 Further research is necessary to understand whether NSAIDs influence the long-term outcomes of recovery from tendinopathy.
Gross42 also alerted us to the fact that clinically, a single subfailure overload injury can develop into a chronic tendinopathy—this observation is supported by animal studies using partial failure models94 in that tendon disruption with histology very similar to that reported in humans103 can persist 12 months after an acute injury. Clinically, it can be very difficult to distinguish partial tears (ie, macroscopic partial defect of acute onset and marked functional deficit) from tendinopathies (which typically demonstrate a more insidious onset of pain and loss of function).50 Histologically, partial tears and tendinopathies have the same appearance,9 but the extent of tissue affected in a partial tear may necessitate a different approach to finding the optimal load to allow healing and remodeling (eg, extensive partial Achilles ruptures may benefit from a period of immobilization to prevent disruption of the healing area, much as one would protect a conservatively managed complete Achilles rupture).99
Mechanisms of Injury
The mechanism of injury for a given tendinopathy can vary from region to region, and from patient to patient. Tendons and their insertions are rarely loaded purely in tension; although tensile overload may be the dominant mechanism for many tendinopathies, there is often compression of the tendon as well, either internally (eg, one fascicle or bundle of fibers against another) or against external structures (paratendon, retinacula, bone). The combination of tension and compression results in shearing and friction. For example, the rotator cuff may experience substantial shearing forces when coming in contact with the acromion and subacromial bursa, particularly if the tendon and/or bursa are thickened, or against the glenoid labrum in positions of extreme external rotation.97 The common extensor tendons of the wrist and fingers at the elbow may be injured not only by repetitive tensile loading, but also by shearing forces against the capitellum with rotation.20 In the Achilles region, shearing and torsional forces could result from the differential displacement of gastrocnemius and soleus tendon components, the “whipping/wringing” effect of excessive pronation, or friction against the adjacent plantaris tendon.2,18,24
Another aspect of pathomechanics that may be clinically relevant is that of tendon “stress shielding,” as well as de-adaptation (“use it or lose it”). Stress shielding refers to the existence of a zone within a tissue that receives less load compared to surrounding areas due to the microinjury of collagen fibers7 or to the uneven distribution of forces (eg, it has been proposed that there may be differential force distribution through the patellar tendon30). Reduction of load through tendons (eg, bed rest or relative inactivity) can lead to a large and rapid loss of structural organization and mechanical properties.82 Thus, a period of relative inactivity followed by a sudden increase in loading may precipitate a tendon injury.
Once symptoms and pain develop, ensuing movement dysfunction may contribute to the chronicity of symptoms. Tendon pain causes widespread motor inhibition in the affected region, evidenced by decreased muscular activity as assessed with electromyography.46 Individuals with tendinopathy also tend to use movement patterns that place excessive or abnormal load on their tendons: the faulty movement may represent either a root cause or a reason for chronicity or slow resolution. For example, the results of several studies focusing on the relationship between jump biomechanics and patellar tendinopathy suggest that individuals with patellar tendinopathy have a less upright position (more hip and knee flexion) at initial contact in landing.107 In individuals with rotator cuff tendinopathy or tear, scapular dyskinesia is a common finding.43,52 More prospective studies are needed, but normalizing movement patterns with the goal of optimizing the loading environment of the tendon seems to be a reasonable approach.53
Classification of Tendinopathies According to Relevant Pathophysiological Features
The pathophysiology features described above lead to the following classification and staging system for tendinopathy (TABLE 1). The classification is meant to alert clinicians to the fact that not all tendinopathies are the same and to facilitate clinical reasoning and communication. This system has not been extensively validated (level 5 evidence) but is rooted in the research evidence presented above, and we hope that readers will find it clinically useful.
Clinical Feature | Classification |
---|---|
Time | Acute, less than 4 wk |
Subacute, 5 to 12 wk | |
Chronic, greater than 12 wk | |
Acute on chronic | |
Tissue affected (more than 1 can be affected) | Tendon |
Enthesis | |
Paratendon | |
Tenosynovial sheath | |
Additional features | Increased color Doppler signal and fluid around (as opposed to within) a tendon suggesting inflammation (tenosynovitis, paratendonitis) |
Calcification (primary or dystrophic) | |
Bony deformity (eg, subacromial spur, insertional irregularity suggestive of inflammatory enthesitis) | |
Bursitis (some will communicate with tendon sheath) | |
Adjacent structures (eg, underlying joint pathology) | |
Degree of tissue disruption on cross-section at any site | Grade 1, less than 10% |
Grade 2, 10% to 50% | |
Grade 3, greater than 50% cross-sectional area (eg, on transverse ultrasound or magnetic resonance imaging) | |
Underlying (risk) factors | Intrinsic risk factors (biomechanics, family history, sex, age) |
Extrinsic risk factors (training errors, sport or occupational demands, etc) | |
Medical conditions |
As an example of how this classification system may be helpful in considering different treatment options, compare and contrast the implications of a case labeled “chronic, grade 3 insertional Achilles tendinopathy with underlying type 2 diabetes mellitus” with those of a case labeled “acute, grade 1 Achilles midportion tendinopathy with paratendonitis and increased pronation during weight bearing.” Therapy in the first clinical scenario should proceed cautiously and patiently, with an exercise-based approach to stimulate adaptation and repair, perhaps in combination with techniques to offload the tendon insertion (eg, heel lifts) and avoiding positions of extreme dorsiflexion, which could further exacerbate the injured enthesis. In the second clinical scenario, the individual may be able to return to full activity rapidly if the biomechanical fault can be adequately addressed with a trial of taping,100 for example, followed by the potential use of orthoses and strengthening of the intrinsic foot musculature. Each patient can present with a unique cluster of features that precludes a “recipe book” approach to physical therapy management. Based on clinical experience and knowledge of underlying pathophysiology, certain features may require more caution (eg, diabetes, advanced age), a different type of load management (eg, relative rest for more acute presentation, heavy controlled loading for more chronic presentation), a balancing of rehabilitation loading with sport or work requirements, and biomechanical considerations (eg, offloading insertion and addressing individual impairments of strength, range of motion, and motor control).
Extrinsic and Intrinsic Factors Associated With Tendinopathy
Józsa and Kannus' classic 1997 text48 summarizes a number of clinical features that place tendons at risk of overuse injury. As each patient may present with a unique cluster of relevant risk factors,66 the clinician must decide which of these to emphasize in assessment and treatment. Extrinsic factors include excessive volume, magnitude, or speed of loading; training errors such as the use of poor-quality equipment and abrupt or acute changes in amount or type of load (eg, sudden change to a different shoe type); and environmental conditions such as temperature (eg, cold weather, which makes the tendon stiffer and reduces its circulation) and running surface. Intrinsic factors include individual biomechanics (malalignments, muscle weakness or imbalance, decreased flexibility), age, and adiposity. Some of these risk factors have now been observed in controlled prospective or retrospective studies.12,44,60,61,67,70,71,77–79,83,107,108,110 At the highest level of activity, tendinopathy is nearly universally prevalent in some sports (eg, radiologically diagnosed rotator cuff tendinopathy in elite swimmers).96 Rehabilitation programs emphasizing individualized biomechanics and overall movement/function have recently been validated in large randomized controlled trials,47,109 underlining the potential importance of biomechanics in the etiology of tendinopathy.
With regard to adiposity as a risk factor for tendinopathy, an association between elevated body mass index and increased risk of tendinopathy appears to hold true both for lower extremity tendons (Achilles, patellar) and upper extremity tendons (rotator cuff, common wrist extensor tendon at the elbow).38 The biological mechanisms have not yet been established, but excessive dietary intake of cholesterol does result in the accumulation of oxidized low-density lipoprotein in the load-bearing region of tendon, where it impairs type I collagen production and reduces tendon strength and energy-storage capacity.95 Individuals with tendinopathy who have a body mass index or waist girth above healthy reference values could be informed that their diet or their weight may be contributing to their tendon condition, and an appropriate exercise prescription made (and perhaps a lipid profile should be suggested if it has not been done recently). Generalized exercise targeted at weight loss, for example, for the overweight individual with rotator cuff tendinopathy or golfer's elbow, may also address concomitant features of chronic musculoskeletal pain syndromes, such as decreased pain threshold and emotional depression.
Smoking is also associated with worse tendon histology than that seen in nonsmokers.63
Medications
In the following section, we provide an update on the role certain medications are now known to play in causing or exacerbating tendinopathy.55 A complete history of any patient will always include the list of their medications, but patients with tendinopathy should specifically be asked about the medications listed below. Tendon pathology caused by medications may present similarly to an overuse condition (eg, gradual onset and pain and swelling aggravated by activity, features typical of statin-induced tendinopathy), or the onset may be sudden, at times characterized by a spontaneous rupture (as characteristic of many fluoroquinolone-induced tendinopathies).
Statins
Statin-induced tendinopathy was first reported in the 2000s.55 The predominant musculoskeletal complaint with this class of drugs is myalgia, but tendinopathy (in the form of tendinosis and tenosynovitis) is also a side effect. The incidence of statin-induced tendinopathy is not known, but it is thought to be rare, accounting for approximately 2% of all complications in one study.68 As with fluoroquinolones, the main location is the Achilles tendon, and other reported sites are the rotator cuff and lateral elbow. The median time of onset is 10 months, and about one third of cases result in frank rupture.55
Fluoroquinolones
Fluoroquinolones are a class of synthetic antimicrobial drugs, including commonly used medications such as ciprofloxacin and levofloxacin. The fact that tendinopathy can occur as a side effect of these drugs was not widely recognized until the early 2000s.55 The estimated rate of tendinopathy in response to fluoroquinolone treatment is 0.5% to 2.0%, with the Achilles tendon being the most commonly affected (about 90% of cases, of which about half are bilateral).51 Other reported sites include the rotator cuff, lateral elbow, finger and thumb flexors, and quadriceps tendon. The onset is usually acute (median duration, 8 days after beginning treatment). Approximately 40% of cases affecting the Achilles tendon proceed to frank rupture.51 Those at greatest risk of fluoroquinolone-induced tendinopathy are people over 60 years of age, people receiving concomitant corticosteroid therapy, those with renal problems, or patients with pre-existing tendinopathy.51
Corticosteroids
Corticosteroids can impair local collagen synthesis, resulting in tendon atrophy, reduction of tensile strength, and hence decreased load to failure.14,28,49 The potential for complete tendon rupture with loading after steroid injection is recognized, although the literature is limited to case reports.106 Rigorous studies have not been performed. However, local steroid injections in the vicinity of the Achilles or patellar tendon and in the presence of severe tendinosis or a tear are frequently discouraged due to the concerns with respect to rupture of heavily loaded tendons and/or impairment of tissue repair where disruption is already present.17,48
Other Causative or Contributing Medical Conditions
A number of medical conditions are associated with tendinopathies and ought to be considered relevant when conducting the history and clinical examination. These are described in TABLE 2. Some patients present with multiple tendon injuries, with or without a family history. Despite the fact that a number of gene variants associated with increased risk of tendon injury or tendinopathy have been identified,98 there is no clinically useful genetic test for these; however, a positive family history or tendinopathies at multiple locations could signal elevated risk.
Site Typically Affected | Examples of Medical Conditions |
---|---|
Mid portion | Dyslipidemias, rheumatoid disease, tumors, infections, storage diseases, gout, pseudogout, heritable connective tissue diseases, hemachromatosis, endocrinopathies (including thyroid disease, Cushing syndrome, hypogonadism, menopause), metabolic diseases including diabetes, hypercalcemia |
Enthesis | Psoriasis, gout, pseudogout, spondyloarthropathies, inflammatory bowel disease |
Tendon sheath | Rheumatoid arthritis, infections, tumors |
Conclusion
Although tendons are anatomically designed to withstand extensive mechanical loading, they are prone to injury through a variety of biomechanical and biological mechanisms. The healing response may be slow or incomplete in many individuals, resulting in long-term structural and functional deficits that predispose them to ongoing irritation and pain. However, the clinical presentation and prognosis of tendinopathy can be very individualized (acute or chronic, focal or generalized, paratendon versus tendon, etc), and a detailed assessment of the extent or nature of pathology and risk factors can assist in clinical reasoning.
References
- 1. Neuronal plasticity in relation to nociception and healing of rat Achilles tendon. J Orthop Res. 2003; 21: 432– 441. http://dx.doi.org/10.1016/S0736-0266(02)00207-3 Crossref Medline Google Scholar
- 2. Midportion Achilles tendinosis and the plantaris tendon. Br J Sports Med. 2011; 45: 1023– 1025. http://dx.doi.org/10.1136/bjsports-2011-090217 Crossref Medline Google Scholar
- 3. Effects of repetitive motion on human fibroblasts. Med Sci Sports Exerc. 1993; 25: 603– 607. Crossref Medline Google Scholar
- 4. Evolving inflammatory cell populations in the overused rabbit Achilles tendon [abstract]. Br J Sports Med. 2014; 48: A60– A61. http://dx.doi.org/10.1136/bjsports-2014-094114.92 Crossref Google Scholar
- 5. Nerve-related characteristics of ventral paratendinous tissue in chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc. 2007; 15: 1272– 1279. http://dx.doi.org/10.1007/s00167-007-0364-2 Crossref Medline Google Scholar
- 6. Tenocyte hypercellularity and vascular proliferation in a rabbit model of tendinopathy: contralateral effects suggest the involvement of central neuronal mechanisms. Br J Sports Med. 2011; 45: 399– 406. http://dx.doi.org/10.1136/bjsm.2009.068122 Crossref Medline Google Scholar
- 7. The mechanobiological aetiopathogenesis of tendinopathy: is it the over-stimulation or the under-stimulation of tendon cells? Int J Exp Pathol. 2007; 88: 217– 226. http://dx.doi.org/10.1111/j.1365-2613.2007.00548.x Crossref Medline Google Scholar
- 8. Tendinopathy alters mechanical and material properties of the Achilles tendon. J Appl Physiol (1985). 2010; 108: 670– 675. http://dx.doi.org/10.1152/japplphysiol.00259.2009 Crossref Medline Google Scholar
- 9. Partial rupture in chronic Achilles tendinopathy: a retrospective analysis of 342 cases. Acta Orthop Scand. 1998; 69: 404– 407. http://dx.doi.org/10.3109/17453679808999056 Crossref Medline Google Scholar
- 10. Chronic Achilles paratenonitis with tendinosis: an experimental model in the rabbit. J Orthop Res. 1990; 8: 541– 547. http://dx.doi.org/10.1002/jor.1100080410 Crossref Medline Google Scholar
- 11. Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathy-peptidergic elevation preceding tendinosis-like tissue changes. J Musculoskelet Neuronal Interact. 2011; 11: 133– 140. Medline Google Scholar
- 12. Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med. 2011; 39: 2626– 2633. http://dx.doi.org/10.1177/0363546511420552 Crossref Medline Google Scholar
- 13. Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation. PLoS One. 2011; 6: e27209. http://dx.doi.org/10.1371/journal.pone.0027209 Crossref Medline Google Scholar
- 14. The effect of injection of hydrocortisone into rabbit calcaneal tendons. J Bone Joint Surg Br. 1972; 54: 729– 734. Crossref Medline Google Scholar
- 15. Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res. 2003; 21: 167– 176. http://dx.doi.org/10.1016/S0736-0266(02)00086-4 Crossref Medline Google Scholar
- 16. Mast cells exert pro-inflammatory effects of relevance to the pathophyisology [sic] of tendinopathy. Arthritis Res Ther. 2013; 15: R184. http://dx.doi.org/10.1186/ar4374 Crossref Medline Google Scholar
- 17. Achilles and patellar tendinopathies in athletes: pathogenesis and surgical treatment. Bull Hosp Jt Dis. 1996; 54: 236– 240. Medline Google Scholar
- 18. Differential displacement of the human soleus and medial gastrocnemius aponeuroses during isometric plantar flexor contractions in vivo. J Appl Physiol (1985). 2004; 97: 1908– 1914. http://dx.doi.org/10.1152/japplphysiol.00084.2004 Crossref Medline Google Scholar
- 19. The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med. 2014; 46: 294– 306. http://dx.doi.org/10.2340/16501977-1800 Crossref Medline Google Scholar
- 20. Anatomic factors related to the cause of tennis elbow. J Bone Joint Surg Am. 2007; 89: 1955– 1963. http://dx.doi.org/10.2106/JBJS.F.00727 Crossref Medline Google Scholar
- 21. The effect of diclofenac on matrix metalloproteinase levels in the rotator cuff. Arch Orthop Trauma Surg. 2014; 134: 1739– 1744. http://dx.doi.org/10.1007/s00402-014-2099-0 Crossref Medline Google Scholar
- 22. The influence of indomethacin on biomechanical and biochemical properties of the plantaris longus tendon in the rabbit. Arch Orthop Trauma Surg. 1987; 106: 157– 160. http://dx.doi.org/10.1007/BF00452202 Crossref Medline Google Scholar
- 23. Timing matters: NSAIDs interfere with the late proliferation stage of a repaired rotator cuff tendon healing in rats. Arch Orthop Trauma Surg. 2014; 134: 515– 520. http://dx.doi.org/10.1007/s00402-014-1928-5 Crossref Medline Google Scholar
- 24. Achilles tendinitis and peritendinitis: etiology and treatment. Am J Sports Med. 1984; 12: 179– 184. http://dx.doi.org/10.1177/036354658401200301 Crossref Medline Google Scholar
- 25. The detrimental effects of systemic ibuprofen delivery on tendon healing are time-dependent. Clin Orthop Relat Res. 2014; 472: 2433– 2439. http://dx.doi.org/10.1007/s11999-013-3258-2 Crossref Medline Google Scholar
- 26. The neurohistology of painful and pain-free rotator cuff tendons [abstract]. Br J Sports Med. 2014; 48: A18. http://dx.doi.org/10.1136/bjsports-2014-094114.27 Crossref Medline Google Scholar
- 27. The peripheral neuronal phenotype is important in the pathogenesis of painful human tendinopathy: a systematic review. Clin Orthop Relat Res. 2013; 471: 3036– 3046. http://dx.doi.org/10.1007/s11999-013-3010-y Crossref Medline Google Scholar
- 28. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum. 2014; 43: 570– 576. http://dx.doi.org/10.1016/j.semarthrit.2013.08.006 Crossref Medline Google Scholar
- 29. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014; 48: 952– 956. http://dx.doi.org/10.1136/bjsports-2013-093281 Crossref Medline Google Scholar
- 30. Differential forces within the proximal patellar tendon as an explanation for the characteristic lesion of patellar tendinopathy: an in vivo descriptive experimental study. Am J Sports Med. 2008; 36: 2119– 2127. http://dx.doi.org/10.1177/0363546508319311 Crossref Medline Google Scholar
- 31. Negative effects of parecoxib and indomethacin on tendon healing: an experimental study in rats. Knee Surg Sports Traumatol Arthrosc. 2009; 17: 835– 839. http://dx.doi.org/10.1007/s00167-009-0763-7 Crossref Medline Google Scholar
- 32. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism. Pain. 2009; 147: 36– 45. http://dx.doi.org/10.1016/j.pain.2009.07.031 Crossref Medline Google Scholar
- 33. Rehabilitation of tendon injuries in sport. Sports Med. 1997; 24: 347– 358. http://dx.doi.org/10.2165/00007256-199724050-00006 Crossref Medline Google Scholar
- 34. Increased substance P expression in the trochanteric bursa of patients with greater trochanteric pain syndrome. Rheumatol Int. 2014; 34: 1441– 1448. http://dx.doi.org/10.1007/s00296-014-2957-7 Crossref Medline Google Scholar
- 35. Exposure-dependent increases in IL-1β, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthop Res. 2010; 28: 298– 307. http://dx.doi.org/10.1002/jor.20984 Medline Google Scholar
- 36. Indomethacin and celecoxib improve tendon healing in rats. Acta Orthop Scand. 2003; 74: 465– 469. http://dx.doi.org/10.1080/00016470310017802 Crossref Medline Google Scholar
- 37. Increased expression of transforming growth factor-β1 in patellar tendinosis. Clin Orthop Relat Res. 2002: 174– 183. Crossref Medline Google Scholar
- 38. Is adiposity an under-recognized risk factor for tendinopathy? A systematic review. Arthritis Rheum. 2009; 61: 840– 849. http://dx.doi.org/10.1002/art.24518 Crossref Medline Google Scholar
- 39. Recurrence of Achilles tendon injuries in elite male football players is more common after early return to play: an 11-year follow-up of the UEFA Champions League injury study. Br J Sports Med. 2013; 47: 763– 768. http://dx.doi.org/10.1136/bjsports-2013-092271 Crossref Medline Google Scholar
- 40. Increased serum and musculotendinous fibrogenic proteins following persistent low-grade inflammation in a rat model of long-term upper extremity overuse. PLoS One. 2013; 8: e71875. http://dx.doi.org/10.1371/journal.pone.0071875 Crossref Medline Google Scholar
- 41. Increased substance P in subacromial bursa and shoulder pain in rotator cuff diseases. J Orthop Res. 1998; 16: 618– 621. http://dx.doi.org/10.1002/jor.1100160515 Crossref Medline Google Scholar
- 42. Chronic tendinitis: pathomechanics of injury, factors affecting the healing response, and treatment. J Orthop Sports Phys Ther. 1992; 16: 248– 261. http://dx.doi.org/10.2519/jospt.1992.16.6.248 Link Google Scholar
- 43. Predictors of pain and function in patients with symptomatic, atraumatic full-thickness rotator cuff tears: a time-zero analysis of a prospective patient cohort enrolled in a structured physical therapy program. Am J Sports Med. 2012; 40: 359– 366. http://dx.doi.org/10.1177/0363546511426003 Crossref Medline Google Scholar
- 44. The impact of posture on wrist tendinosis among blue-collar workers: the San Francisco study. Hum Factors. 2014; 56: 143– 150. http://dx.doi.org/10.1177/0018720813502807 Crossref Medline Google Scholar
- 45. Mechanical properties of the patellar tendon in elite volleyball players with and without patellar tendinopathy. Br J Sports Med. 2013; 47: 862– 868. http://dx.doi.org/10.1136/bjsports-2013-092275 Crossref Medline Google Scholar
- 46. Motor responses to experimental Achilles tendon pain. Br J Sports Med. 2011; 45: 393– 398. http://dx.doi.org/10.1136/bjsm.2010.072561 Crossref Medline Google Scholar
- 47. Effect of specific exercise strategy on need for surgery in patients with subacromial impingement syndrome: randomised controlled study. Br J Sports Med. 2014; 48: 1456– 1457. http://dx.doi.org/10.1136/bjsports-2014-e787rep Crossref Medline Google Scholar
- 48. Human Tendons: Anatomy, Physiology, and Pathology. Champaign, IL: Human Kinetics; 1997. Google Scholar
- 49. The effect of the local corticosteroids on the healing and biomechanical properties of the partially injured tendon. Clin Orthop Relat Res. 1982: 170– 179. Medline Google Scholar
- 50. Partial rupture of the proximal Achilles tendon: a differential diagnostic problem in ultrasound imaging. Br J Sports Med. 2005; 39: 838– 842. http://dx.doi.org/10.1136/bjsm.2005.018416 Crossref Medline Google Scholar
- 51. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003; 36: 1404– 1410. http://dx.doi.org/10.1086/375078 Crossref Medline Google Scholar
- 52. The scapula in rotator cuff disease. Med Sport Sci. 2012; 57: 27– 40. http://dx.doi.org/10.1159/000328877 Crossref Medline Google Scholar
- 53. Clinical implications of scapular dyskinesis in shoulder injury: the 2013 consensus statement from the ‘Scapular Summit’. Br J Sports Med. 2013; 47: 877– 885. http://dx.doi.org/10.1136/bjsports-2013-092425 Crossref Medline Google Scholar
- 54. Aging contributes to inflammation in upper extremity tendons and declines in forelimb agility in a rat model of upper extremity overuse. PLoS One. 2012; 7: e46954. http://dx.doi.org/10.1371/journal.pone.0046954 Crossref Medline Google Scholar
- 55. Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine. 2014; 81: 485– 492. http://dx.doi.org/10.1016/j.jbspin.2014.03.022 Crossref Medline Google Scholar
- 56. Stereological quantification of immune-competent cells in baseline biopsy specimens from Achilles tendons: results from patients with chronic tendinopathy followed for more than 4 years. Am J Sports Med. 2014; 42: 2435– 2445. http://dx.doi.org/10.1177/0363546514542329 Crossref Medline Google Scholar
- 57. Chronic Achilles paratenonitis. An immunohistologic study of fibronectin and fibrinogen. Am J Sports Med. 1988; 16: 616– 623. http://dx.doi.org/10.1177/036354658801600611 Crossref Medline Google Scholar
- 58. Cell-matrix response in tendon injury. Clin Sports Med. 1992; 11: 533– 578. Medline Google Scholar
- 59. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology. 2012; 116: 882– 895. http://dx.doi.org/10.1097/ALN.0b013e31824bb303 Crossref Medline Google Scholar
- 60. Achilles tendon injury risk factors associated with running. Sports Med. 2014; 44: 1459– 1472. http://dx.doi.org/10.1007/s40279-014-0209-3 Crossref Medline Google Scholar
- 61. Upper extremity strength characteristics in female recreational tennis players with and without lateral epicondylalgia. J Orthop Sports Phys Ther. 2012; 42: 1025– 1031. http://dx.doi.org/10.2519/jospt.2012.4095 Link Google Scholar
- 62. Histopathological changes in tendinopathy—potential roles of BMPs? Rheumatology (Oxford). 2013; 52: 2116– 2126. http://dx.doi.org/10.1093/rheumatology/ket165 Crossref Medline Google Scholar
- 63. Rotator cuff tear degeneration and cell apoptosis in smokers versus nonsmokers. Arthroscopy. 2014; 30: 936– 941. http://dx.doi.org/10.1016/j.arthro.2014.03.027 Crossref Medline Google Scholar
- 64. Rehabilitation of muscle after injury – the role of anti-inflammatory drugs. Scand J Med Sci Sports. 2012; 22: e8– e14. http://dx.doi.org/10.1111/j.1600-0838.2012.01463.x Crossref Medline Google Scholar
- 65. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy. 1998; 14: 840– 843. http://dx.doi.org/10.1016/s0749-8063(98)70021-0 Crossref Medline Google Scholar
- 66. The pathogenesis of Achilles tendinopathy: a systematic review. Foot Ankle Surg. 2014; 20: 154– 159. http://dx.doi.org/10.1016/j.fas.2014.02.010 Crossref Medline Google Scholar
- 67. Intrinsic risk factors for the development of Achilles tendon overuse injury: a prospective study. Am J Sports Med. 2006; 34: 226– 235. http://dx.doi.org/10.1177/0363546505279918 Crossref Medline Google Scholar
- 68. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Rheum. 2008; 59: 367– 372. http://dx.doi.org/10.1002/art.23309 Crossref Medline Google Scholar
- 69. Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases. J Bone Joint Surg Br. 2006; 88: 489– 495. http://dx.doi.org/10.1302/0301-620X.88B4.16845 Crossref Medline Google Scholar
- 70. Etiologic and pathogenetic factors for rotator cuff tendinopathy. Clin Sports Med. 2003; 22: 791– 812. Crossref Medline Google Scholar
- 71. Cold weather training: a risk factor for Achilles paratendinitis among recruits. Foot Ankle Int. 2003; 24: 398– 401. Crossref Medline Google Scholar
- 72. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010; 38: 2085– 2091. http://dx.doi.org/10.1177/0363546510372613 Crossref Medline Google Scholar
- 73. Cyclic strain alters the expression and release of angiogenic factors by human tendon cells. PLoS One. 2014; 9: e97356. http://dx.doi.org/10.1371/journal.pone.0097356 Crossref Medline Google Scholar
- 74. Tendon pathology in long-standing achillodynia: biopsy findings in 40 patients. Acta Orthop Scand. 1997; 68: 170– 175. http://dx.doi.org/10.3109/17453679709004002 Crossref Medline Google Scholar
- 75. VEGF, VEGFR-1, and CTGF cell densities in tendon are increased with cyclical loading: an in vivo tendinopathy model. J Orthop Res. 2006; 24: 393– 400. http://dx.doi.org/10.1002/jor.20053 Crossref Medline Google Scholar
- 76. Eccentric training in patients with chronic Achilles tendinosis: normalised tendon structure and decreased thickness at follow up. Br J Sports Med. 2004; 38: 8– 11; discussion 11. http://dx.doi.org/10.1136/bjsm.2001.000284 Crossref Medline Google Scholar
- 77. Plantarflexor muscle power deficits in runners with Achilles tendinopathy [abstract]. Br J Sports Med. 2014; 48: A49. http://dx.doi.org/10.1136/bjsports-2014-094114.74 Google Scholar
- 78. Comparison of injury incidences between football teams playing in different climatic regions. Open Access J Sports Med. 2013; 4: 251– 260. http://dx.doi.org/10.2147/OAJSM.S52417 Crossref Medline Google Scholar
- 79. Association between kyphosis and subacromial impingement syndrome: LOHAS study. J Shoulder Elbow Surg. 2014; 23: e300– e307. http://dx.doi.org/10.1016/j.jse.2014.04.010 Crossref Medline Google Scholar
- 80. Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults. Cochrane Database Syst Rev. 2013; 5: CD003686. http://dx.doi.org/10.1002/14651858.CD003686.pub2 Medline Google Scholar
- 81. 3-D ultrastructure and collagen composition of healthy and overloaded human tendon: evidence of tenocyte and matrix buckling. J Anat. 2014; 224: 548– 555. http://dx.doi.org/10.1111/joa.12164 Crossref Medline Google Scholar
- 82. Influence of 90-day simulated microgravity on human tendon mechanical properties and the effect of resistive countermeasures. J Appl Physiol (1985). 2005; 98: 2278– 2286. http://dx.doi.org/10.1152/japplphysiol.01266.2004 Crossref Medline Google Scholar
- 83. Relation between ankle joint dynamics and patellar tendinopathy in elite volleyball players. Clin J Sport Med. 2002; 12: 266– 272. http://dx.doi.org/10.1097/00042752-200209000-00002 Crossref Medline Google Scholar
- 84. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford). 2004; 43: 131– 142. http://dx.doi.org/10.1093/rheumatology/keg448 Crossref Medline Google Scholar
- 85. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg Br. 2001; 26: 224– 228. http://dx.doi.org/10.1054/jhsb.2001.0560 Crossref Medline Google Scholar
- 86. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res. 2003; 287: 289– 300. http://dx.doi.org/10.1016/s0014-4827(03)00107-1 Crossref Medline Google Scholar
- 87. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem. 2011; 112: 2748– 2758. http://dx.doi.org/10.1002/jcb.23225 Crossref Medline Google Scholar
- 88. Degeneration at the insertion weakens the tensile strength of the supraspinatus tendon: a comparative mechanical and histologic study of the bone-tendon complex. J Orthop Res. 1997; 15: 719– 726. http://dx.doi.org/10.1002/jor.1100150514 Crossref Medline Google Scholar
- 89. Healing of human Achilles tendon ruptures: radiodensity reflects mechanical properties. Knee Surg Sports Traumatol Arthrosc. 2015; 23: 884– 889. http://dx.doi.org/10.1007/s00167-013-2720-8 Crossref Medline Google Scholar
- 90. Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann Rheum Dis. 2005; 64: 1083– 1086. http://dx.doi.org/10.1136/ard.2004.029876 Crossref Medline Google Scholar
- 91. Human tendon overuse pathology: histopathological and biochemical findings. In: Woo SL, , Renström PA, and Arnoczky SP, eds. Tendinopathy in Athletes. Malden, MA: Blackwell; 2007: 69– 84. Crossref Google Scholar
- 92. What do we mean by the term “inflammation”? A contemporary basic science update for sports medicine. Br J Sports Med. 2004; 38: 372– 380. http://dx.doi.org/10.1136/bjsm.2004.011312 Crossref Medline Google Scholar
- 93. Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee. Scand J Med Sci Sports. 2008; 18: 427– 435. http://dx.doi.org/10.1111/j.1600-0838.2007.00735.x Crossref Medline Google Scholar
- 94. Scleraxis expression is coordinately regulated in a murine model of patellar tendon injury. J Orthop Res. 2011; 29: 289– 296. http://dx.doi.org/10.1002/jor.21220 Crossref Medline Google Scholar
- 95. Lipids, adiposity and tendinopathy: is there a mechanistic link? Critical review. Br J Sports Med. 2015; 49: 984– 988. http://dx.doi.org/10.1136/bjsports-2014-093989 Crossref Medline Google Scholar
- 96. Shoulder pain in elite swimmers: primarily due to swim-volume-induced supraspinatus tendinopathy. Br J Sports Med. 2010; 44: 105– 113. http://dx.doi.org/10.1136/bjsm.2008.047282 Crossref Medline Google Scholar
- 97. Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin Biomech (Bristol, Avon). 2011; 26: 1– 12. http://dx.doi.org/10.1016/j.clinbiomech.2010.08.001 Crossref Medline Google Scholar
- 98. Application of genomics in the prevention, treatment and management of Achilles tendinopathy and anterior cruciate ligament ruptures. Recent Pat DNA Gene Seq. 2012; 6: 216– 223. http://dx.doi.org/10.2174/187221512802717358 Crossref Medline Google Scholar
- 99. Achilles tendon disorders in runners-a review. Med Sci Sports Exerc. 1980; 12: 231– 243. http://dx.doi.org/10.1249/00005768-198024000-00002 Crossref Medline Google Scholar
- 100. Use of anti-pronation taping to assess suitability of orthotic prescription: case report. Aust J Physiother. 2004; 50: 111– 113. Crossref Medline Google Scholar
- 101. Early inflammatory response of tenocytes to overload [abstract]. Br J Sports Med. 2014; 48: A63– A64. http://dx.doi.org/10.1136/bjsports-2014-094114.97 Crossref Medline Google Scholar
- 102. The effects of prolonged peritendinous administration of PGE1 to the rat Achilles tendon: a possible animal model of chronic Achilles tendinopathy. J Orthop Sci. 2001; 6: 349– 357. http://dx.doi.org/10.1007/s007760100031 Crossref Medline Google Scholar
- 103. A long-term serial histological evaluation of the patellar tendon in humans after harvesting its central third. Knee Surg Sports Traumatol Arthrosc. 2005; 13: 398– 404. http://dx.doi.org/10.1007/s00167-004-0590-9 Crossref Medline Google Scholar
- 104. Effects of indomethacin on adhesion formation after repair of zone II tendon lacerations in the rabbit. J Hand Surg Am. 1990; 15: 480– 483. http://dx.doi.org/10.1016/0363-5023(90)90066-Z Crossref Medline Google Scholar
- 105. The effect of indomethacin on Achilles tendon healing in rabbits. Clin Orthop Relat Res. 1991: 308– 311. Medline Google Scholar
- 106. Complete Achilles tendon rupture after local infiltration of corticosteroids in the treatment of deep retrocalcaneal bursitis. J Ultrasound. 2014; 17: 165– 167. http://dx.doi.org/10.1007/s40477-014-0066-9 Crossref Medline Google Scholar
- 107. Jumper's knee or lander's knee? A systematic review of the relation between jump biomechanics and patellar tendinopathy. Int J Sports Med. 2014; 35: 714– 722. http://dx.doi.org/10.1055/s-0033-1358674 Crossref Medline Google Scholar
- 108. Intrinsic gait-related risk factors for Achilles tendinopathy in novice runners: a prospective study. Gait Posture. 2009; 29: 387– 391. http://dx.doi.org/10.1016/j.gaitpost.2008.10.058 Crossref Medline Google Scholar
- 109. Specific manipulative therapy treatment for chronic lateral epicondylalgia produces uniquely characteristic hypoalgesia. Man Ther. 2001; 6: 205– 212. http://dx.doi.org/10.1054/math.2001.0411 Crossref Medline Google Scholar
- 110. Intrinsic risk factors for the development of patellar tendinitis in an athletic population: a two-year prospective study. Am J Sports Med. 2001; 29: 190– 195. Crossref Medline Google Scholar
- 111. Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products. Ann Rheum Dis. 1988; 47: 328– 332. http://dx.doi.org/10.1136/ard.47.4.328 Crossref Medline Google Scholar